The effect of pulsed electromagnetic stimulation on the improvement of urinary symptoms in women with urinary incontinence

Evaluation of the Efficacy and safety of Pulsed Electromagnetic Stimulation on the improvement of urinary symptoms in women with urge incontinence, stress incontinence and mixed (urge/stress) incontinence referred to a private urinary incontinence treatment clinic

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201710034582N7

Enrollment

100

Registered

2017-11-13

Start date

2017-11-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary incontinence. Other specified urinary incontinence

Interventions

Pulse electromagnetic stimulation using a NOVAmag NT-60 device for 6 weeks, a weekly two sessions and each session for 20 minutes.

Rehabilitation

Pulse electromagnetic stimulation using a NOVAmag NT-60 device for 6 weeks, a weekly two sessions and each session for 20 minutes

Eligibility

Sex/Gender

Female

Age

21 Years to 139 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: At least 21 years of age; ability to read and write; having one of the types of stress; urge or mixed incontinence Exclusion Criteria: Overflow urinary incontinence; acute and severe pelvic infections; severe heart arrhythmia; known psychological disease history; neurological disorders such as stroke; parkinson; epilepsy and MS; current pregnancy; previous surgery for treatment of incontinence; history of pelvic or gynecologic surgery in last 3 weeks or next coming 8 weeks; pelvic organs prolapsed surgery; trauma of pelvis or perineum; neurogenic bladder; previous magnetic stimulation therapy; simultaneous use of alpha adrenergic agonist drugs (terazosin, tamsulosin, doxazosin), diuretics and or using any drugs that exacerbate incontinence; pelvic organs prolapsed (POP); doubt to the bladder fistula; urinary tract infection or hematuria; residual urine volume>200 milliliters

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Treatment of urinary incontinence. Timepoint: 3 and 6 months after intervention. Method of measurement: Calculate the relevant questions in the BFLUTS standard questionnaire.;Reducing the number of used pads. Timepoint: 3 and 6 months after intervention. Method of measurement: Calculate the relevant questions in the BFLUTS standard questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Mohammadalizadeh

Urology Research Center, Guilan University of Medical Sciences

urc1384@yahoo.com+98 13 3352 5259

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026